Moderna Inc: COVID19 Vaccine 94.5% effective

Moderna Inc: COVID19 Vaccine 94.5% effective


November 16, 2020

Moderna Inc announced Monday that its experimental vaccine was 94.5% effective in preventing COVID-19. They noted that the information was based on “interim data from a late-stage clinical trial.”

Moderna follows Pfizer in producing a vaccine against the deadly COVID19 virus. President Donald Trump and his administration hailed the new vaccine as a success and its push to get a vaccine to the public through its initiative Operation Warp Speed.

White House press secretary Kayleigh McEnany “Big News!”

Trending: What Was In Those Bush Sr. Funeral Envelopes and Why Did Mike Pence Get One?

“Thanks to President @realDonaldTrump’s highly successful Operation Warp Speed, a second vaccine (Moderna) has shown high efficacy in Phase 3 clinical trial,” McEnany said on Twitter. “This news comes just after Pfizer likewise proved successful. Big wins for all!!”

🚨🚨BIG NEWS! 🚨🚨

Thanks to President @realDonaldTrump’s highly successful Operation Warp Speed, a second vaccine (Moderna) has shown high efficacy in Phase 3 clinical trial.

This news comes just after Pfizer likewise proved successful. Big wins for all‼️

Continue reading

You Might Like

Do NOT follow this link or you will be banned from the site!
Send this to a friend